Sicagen India Ltd (SICAGEN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sicagen India Ltd on NSE and BSE, with an AI summary of each filing.
Un-audited Financial (Standalone & Consolidated) Results of the Company for the Quarter & Half Year ended 30th September, 2026.
Financial Result · 02 Nov 2026, 6:49 pm
Outcome of the Board Meeting dated 02nd November, 2026.
Outcome · 02 Nov 2026, 6:42 pm
Sicagen India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 32,795 (+44.6% YoY | +14.7% QoQ) ■ EBITDA: 1,489 (+64.3% YoY | +20.0% QoQ) ■ EBITDA Margin (%): 4.5 (+54 bps YoY | +20 bps QoQ) ■ PAT: 896 (+116.4% YoY | +29.3% QoQ) ■ EPS (INR): 2.26 (+115.2% YoY | +29.1% QoQ) Sicagen India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Trading ■ Revenue: 14,608 (+21.7% YoY | -9.1% QoQ) ■ EBIT: 641 (+82.6% YoY | -15.1% QoQ) ■ EBIT Margin (%): 4.4 (+146 bps YoY | -31 bps QoQ) Manufacturing ■ Revenue: 18,188 (+69.4% YoY | +45.2% QoQ) ■ EBIT: 935 (+51.5% YoY | +55.3% QoQ) ■ EBIT Margin (%): 5.1 (-61 bps YoY | +33 bps QoQ)
Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-audited Financial (both Standalone ....
Intimation · 02 Nov 2026, 5:30 am
Sicagen India Board to Consider Q2 FY27 Financial Results on 2nd Nov'26 Sicagen India's Board of Directors is scheduled to meet on 2nd Nov'26 to consider and approve the standalone and consolidated un-audited financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in the company's equity shares by designated persons and immediate relatives remains closed from 1st Oct'26 until 48 hours post the declaration of the financial results.
Scrutinizer''s Report for the 22nd AGM - 2026
Annual General Meeting · 19 Sept 2026, 1:45 am
Proceedings of the 22nd Annual General Meeting of the Company
Annual General Meeting · 18 Sept 2026, 1:03 am
Letters dispatch to shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015 is attached herewith.
Others (Uncategorized) · 27 Aug 2026, 11:39 pm
Sicagen India Announces FY26 Annual Report and AGM Details Sicagen India has scheduled its 22nd Annual General Meeting (AGM) for 17th Sep'26 at 3:30 p.m. IST, to be held via video conferencing. The company has released its Annual Report for the financial year 2025-26, making it available on its website. This communication, dated 25th Aug'26, fulfills SEBI (LODR) Regulation 36(1)(b) by providing a direct weblink to the report for shareholders who have not registered an email address with the company or its depositories.
Please find enclosed a copy of letters sent to physical shareholders intimating to update their PAN/KYC/Nomination details with RTA of the Company.
Others (Uncategorized) · 26 Aug 2026, 10:54 pm
Sicagen Reminds Physical Shareholders of Mandatory KYC Update Sicagen India has formally notified its physical shareholders of the mandatory requirement to update their PAN, KYC, and nomination details. This action, communicated on 26-Aug-26, complies with SEBI circulars dated 06-Feb-26 and 10-Jun-24. Shareholders must submit the required forms and documents to the Registrar and Transfer Agent (RTA), Cameo Corporate Services. The company has clarified that service requests and dividends for physical folios will be processed only upon completion of KYC, with unpaid dividends held until compliance is met.
Notice of 22nd Annual General Meeting of the Company which is scheduled to be held on Thursday, 17th September, 2026 at 03:30 p.m. (IST) through VC/OAVM.
Annual General Meeting · 25 Aug 2026, 7:38 pm
22nd Annual Report of the Company for the FY 2025-26
Others (Uncategorized) · 25 Aug 2026, 7:31 pm
22nd Annual General Meeting of the Company will be held on Thursday, 17th September, 2026. The register of members will be closed from 11th September, 2026 to 17th September, 2026 (both ....
Annual General Meeting · 10 Aug 2026, 6:48 pm
Unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter ended 30th June, 2026 together with the Limited Review Reports of the Auditors thereon.
Financial Result · 10 Aug 2026, 6:36 pm
Sicagen Q1 FY27 Net Profit Rises Sharply YoY; Sets AGM & Dividend Record Date Sicagen India reported strong standalone results for Q1 FY27 ending 30th Jun'26. Net profit grew 49.3% YoY to ₹548 lakhs, while revenue from operations increased 9.3% YoY to ₹13,293 lakhs. EPS stood at ₹1.38, up from ₹0.93 YoY. On a consolidated basis, net profit rose 52.6% YoY to ₹693 lakhs on revenue of ₹28,596 lakhs. The board scheduled the 22nd AGM for 17th Sep'26 and set 10th Sep'26 as the record date for any dividend declared for FY26.
The Board of Directors of the Company in their meeting held on 10.08.2026 i.e. today has inter-alia considered and approved the Unaudited Financial Results (both Standalone & Consolidated) ....
Outcome · 10 Aug 2026, 6:08 pm
Sicagen India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 28,596 (+39.8% YoY | +2.9% QoQ) ■ EBITDA: 1,241 (+27.4% YoY | +10.5% QoQ) ■ EBITDA Margin (%): 4.3 (-42 bps YoY | +30 bps QoQ) ■ PAT: 693 (+52.6% YoY | +55.4% QoQ) ■ EPS (INR): 1.75 (+52.2% YoY | +54.9% QoQ) Sicagen India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) Segmental Performance Trading ■ Revenue: 16,070 (+44.5% YoY | +5.3% QoQ) ■ EBIT: 755 (+42.5% YoY | +69.3% QoQ) ■ EBIT Margin (%): 4.7 (-7 bps YoY | +177 bps QoQ) Manufacturing ■ Revenue: 12,526 (+34.2% YoY | -0.1% QoQ) ■ EBIT: 602 (+21.4% YoY | -7.0% QoQ) ■ EBIT Margin (%): 4.8 (-51 bps YoY | -36 bps QoQ)
Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Un-audited Financial Results ....
Intimation · 10 Aug 2026, 5:30 am
Sicagen India Board Meeting to Approve Q1FY27 Results Sicagen India has scheduled a Board of Directors meeting for 10th Aug '26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Jun '26. The trading window for designated persons has been closed from 1st Jul '26 and will reopen 48 hours after the results are declared.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Twinshield Consultants Pvt Ltd
Acquisition/ Disposal of Shares · 22 Jun 2026, 9:31 pm
Sicagen India: Promoter Group Hikes Stake via Off-Market Transaction Twinshield Consultants, part of Sicagen India's promoter group, acquired 15,45,500 equity shares (3.90% stake) via an off-market transaction on 19-Jun'26. This purchase increased the promoter group's total holding in Sicagen India from 69,02,634 shares (17.44%) to 84,48,134 shares (21.34%). The acquisition was disclosed under SEBI (SAST) Regulations, 2011. The company's total voting capital remains unchanged at 3,95,71,684 equity shares post-acquisition. This move signals strengthening promoter conviction in the company.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for South India Travels Pvt Ltd
Acquisition/ Disposal of Shares · 22 Jun 2026, 9:27 pm
Sicagen India: Promoter Group Entity Sells 3.9% Stake in Off-Market Deal Promoter group entity, South India Travels Private Limited, sold 15,45,500 equity shares of Sicagen India (BSE: 533014) in an off-market transaction. This represents 3.90% of the company's total voting capital. The sale reduces the entity's holding from 19,40,113 shares (4.90% stake) to 3,94,613 shares (1.00% stake). The total equity share capital of Sicagen India remains at 3,95,71,684 shares. This disclosure is pursuant to SEBI (SAST) Regulations, 2011.
Intimation about resignation of Mr. Nandakumar Varma (DIN : 09776904) from the Whole-Time Directorship of the Company at the closure of Business Hours on 13.05.2026.
Change in Management · 14 May 2026, 12:09 am
Sicagen Board Announces Dividend, Appoints New Whole-Time Director Sicagen India's board approved Q4 and FY26 results and recommended a 10% equity dividend (Re. 1/share) for FY26, pending shareholder approval. Following the resignation of Whole-Time Director Nandakumar Varma on 13 May'26, the company appointed Mr. Prasanna Joshi, previously VP of the Building Material Division, as the new Whole-Time Director (Executive) for a 3-year term starting 14 May'26. The auditor's report on the financial results contained an unmodified opinion. M/s. Venkatesh & Co. were appointed as internal auditors for FY27.
Announcement regarding Change in Senior Management Personnel under Reg 30 of SEBI (LODR) Regulations, 2015.
Change in Management · 14 May 2026, 12:00 am
Sicagen Board Approves FY26 Results, Dividend, and Directorate Changes Sicagen's Board approved audited financial results for the quarter and year ended 31st Mar'26, along with an unmodified auditor's report. A 10% equity dividend (Re. 1/share) was recommended for FY25-26, subject to shareholder approval. The Board also announced key directorate changes effective 14th May'26: Mr. Nandakumar Varma resigned as Whole-Time Director, and Mr. Prasanna Joshi has been appointed as his replacement for a 3-year term. Mr. K R Jaikumar was designated as Senior Management Personnel from 13th May'26.
Announcement regarding Change in Directorate under Reg 30 of SEBI(LODR) Regulations, 2015.
Change in Management · 13 May 2026, 11:55 pm
Sicagen Board Announces Dividend, Appoints New Whole-Time Director Sicagen India's Board approved FY26 audited results and recommended a 10% equity dividend of Re. 1 per share, subject to shareholder approval. Concurrently, Mr. Prasanna Joshi, a 13-year company veteran, was appointed as Whole-Time Director for a three-year term effective 14th May'26. This follows the resignation of Mr. Nandakumar Varma from the same role on 13th May'26. The auditor's report on the financial results carried an unmodified opinion. M/s. Venkatesh & Co. were appointed as internal auditors for FY27.
The Board of Directors in their meeting held on 13.05.2026 has recommended the equity dividend @ 10% (Re. 1.00 per share) on the equity capital of the Company for the FY 2025-26.
Dividend · 13 May 2026, 11:46 pm
Sicagen Board Announces FY26 Dividend and Key Director Changes Sicagen's board approved audited financial results for the quarter and year ended 31st Mar'26, along with an unmodified auditor's report. A 10% equity dividend (Re. 1/- per share) has been recommended for FY25-26, subject to shareholder approval. Concurrently, Mr. Nandakumar Varma resigned as Whole-Time Director effective 13th May'26. Mr. Prasanna Joshi has been appointed as his replacement for a 3-year term starting 14th May'26, pending shareholder approval. The board also appointed M/s. Venkatesh & Co. as internal auditors for FY26-27.
Audited Financial Results (both Standalone & Consolidated) of the Company for the Quarter & year ended on 31.03.2026 together with the Auditors Report thereon.
Financial Result · 13 May 2026, 11:34 pm
Sicagen India Limited - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 27791 (+10.5% YoY | +5.2% QoQ) ■ EBITDA: 1123 (+5.8% YoY | +21.1% QoQ) ■ EBITDA Margin (%): 4.0 (-18 bps YoY | +53 bps QoQ) ■ PAT: -2265 (Profit to Loss YoY | -377.8% QoQ) ■ EPS (INR): 1.13 (+13.0% YoY | -9.6% QoQ) Sicagen India Limited - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) Segmental Performance Trading ■ Revenue: 15256 (-5.2% YoY | +2.7% QoQ) ■ EBIT: 446 (+50.2% YoY | -3.9% QoQ) ■ EBIT Margin (%): 2.9 (+108 bps YoY | -20 bps QoQ) Manufacturing ■ Revenue: 12536 (+38.4% YoY | +8.3% QoQ) ■ EBIT: 647 (+20.5% YoY | +21.6% QoQ) ■ EBIT Margin (%): 5.2 (-77 bps YoY | +56 bps QoQ)
The Board of Directors of the Company in their meeting held on 13.05.2026 i.e. today, has inter-alia considered and approved the Audited Financial Results (both Standalone & Consolidated) ....
Outcome · 13 May 2026, 11:14 pm
Sicagen India Limited - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 27791 (+10.5% YoY | +5.2% QoQ) ■ EBITDA: 1123 (+5.8% YoY | +21.1% QoQ) ■ EBITDA Margin (%): 4.0 (-18 bps YoY | +53 bps QoQ) ■ PAT: -2265 (Profit to Loss YoY | -377.8% QoQ) ■ EPS (INR): 1.13 (+13.0% YoY | -9.6% QoQ) Sicagen India Limited - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) Segmental Performance Trading ■ Revenue: 15256 (-5.2% YoY | +2.7% QoQ) ■ EBIT: 446 (+50.2% YoY | -3.9% QoQ) ■ EBIT Margin (%): 2.9 (+108 bps YoY | -20 bps QoQ) Manufacturing ■ Revenue: 12536 (+38.4% YoY | +8.3% QoQ) ■ EBIT: 647 (+20.5% YoY | +21.6% QoQ) ■ EBIT Margin (%): 5.2 (-77 bps YoY | +56 bps QoQ)
Sicagen India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Intimation · 13 May 2026, 5:30 am
Sicagen India Board Meeting Set for May 13 to Consider Q4FY26 Results and Dividend Sicagen India's Board of Directors will meet on 13th May'26 to consider and approve audited standalone and consolidated financial results for the quarter and year ended 31st Mar'26. The board will also consider and recommend an equity dividend, if any, for the financial year 2025-26. The trading window for designated persons has been closed from 1st Apr'26 and will reopen 48 hours after the results are declared, in compliance with SEBI regulations.
Intimation of Credit Rating re-affirmation
Others (Uncategorized) · 02 May 2026, 1:12 am
Sicagen India Credit Ratings Reaffirmed by Acuité On 30 Apr'26, Acuité Ratings & Research reaffirmed Sicagen India's credit ratings. The rating for its Rs. 25.00 Cr Long-Term Bank Facilities was maintained at ACUITE BBB with a Stable outlook. Concurrently, the rating for its Rs. 23.00 Cr Short-Term Bank Facilities was reaffirmed at ACUITE A3+. The stable outlook suggests low credit risk in the medium term, providing a positive signal regarding the company's financial stability and debt-servicing capabilities.
Intimation about Change in Senior Management Personnel.
Change in Management · 25 Mar 2026, 11:08 pm
Sicagen India: Senior Manager of Speciality Chemical Division Resigns Mr. V. Venkatesh, Senior Manager-Operations (Speciality Chemical Division) and designated Senior Management Personnel (SMP), has resigned from Sicagen India Ltd effective 25th Mar'26. The resignation was accepted and is attributed to personal reasons, with no other material cause cited. Mr. Venkatesh's relieving date will be on or before 20th May'26. This change affects a key management role within the company's Speciality Chemical segment.
Un-audited Financial Results (both Standalone & Consolidated) of the Company for the quarter & nine months ended 31.12.2025.
Financial Result · 30 Jan 2026, 7:03 pm
Sicagen India Q3FY26 Standalone PAT Grows 20% YoY Sicagen India reported standalone results for the quarter ended 31st Dec'25. Net Profit After Tax (PAT) grew 20.2% YoY to ₹393 lakhs from ₹327 lakhs. Revenue from operations increased 9.4% YoY to ₹13,433 lakhs. Total expenses rose 8.1% YoY to ₹13,133 lakhs. The company recorded a one-off exceptional loss of ₹31 lakhs related to the new Labour Codes. QoQ, PAT increased by 82% from ₹216 lakhs, while revenue grew 7.7%. The Board of Directors approved these unaudited financial results on 30th Jan'26.